Ocular manifestations in congenital toxoplasmosis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 1, 2006, Pages 14-21

  Kodjikian, Laurent ^a,b,c,d   Wallon, Martine ^d   Fleury, Jacques ^a   Denis, Philippe ^c   Binquet, Christine ^d   Peyron, François ^d   Garweg, Justus G ^b  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF BERN   (Switzerland)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d CROIX ROUSSE HOSPITAL   (France)

Author keywords

Congenital toxoplasmosis; Infection; Ocular manifestation; Retinochoroiditis; Visual impairment

Indexed keywords

FANSIDAR; FOLINIC ACID; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

ADOLESCENT; ADULT; ARTICLE; CATARACT; CHILD; CHORIORETINITIS; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE DISEASE; FOLLOW UP; HUMAN; INFANT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MICROPHTHALMIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STRABISMUS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; CHORIORETINITIS; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PYRIMETHAMINE; SULFADOXINE; TOXOPLASMOSIS, CONGENITAL; TOXOPLASMOSIS, OCULAR; VISION DISORDERS;

EID: 29544445527     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-1164-3     Document Type: Article

References (21)

1. Binquet C, Wallon M, Quantin C, Kodjikian L, Garweg J, Fleury J, Peyron F, Abrahamowicz M (2003) Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 131:1157-1168 10.1017/S0950268803001316
2. Catford G, Oliver A (1973) Development of visual acuity. Arch Dis Child 48:47-50 1:STN:2080:CSyD2M7nt1C%3D
3. de Jong PT (1989) Ocular toxoplasmosis: Common and rare symptoms and signs. Int Ophthalmol 13:391-397 2697705
4. Fahnehjelm KT, Malm G, Ygge J, Engman ML, Maly E, Evengard B (2000) Ophthalmological findings in children with congenital toxoplasmosis. Report from a Swedish prospective screening study of congenital toxoplasmosis with two years of follow-up. Acta Ophthalmol Scand 78:569-575 10.1034/j.1600-0420.2000.078005569.x
5. Folk JC, Lobes LA (1984) Presumed toxoplasmic papillitis. Ophthalmology 91:64-67
6. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A (1999) Treatment of toxoplasmosis during pregnancy: A multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 180:410-415 1:STN:280:DyaK1M7ktlSnsg%3D%3D
7. Frau E, Gregoire-Cassoux N, Lautier-Frau M, Labetoulle M, Lehoang P, Offret H (1997) Toxoplasmic chorioretinitis complicated by retinal detachment. J Fr Ophtalmol 20:749-752 1:STN:280:DyaK1c3kvFWluw%3D%3D
8. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1:254-625 10.1016/ S0140-6736(86)90785-3
9. Kvarnstrom G, Jakobsson P, Lennerstrand G (1998) Screening for visual and ocular disorders in children, evaluation of the system in Sweden. Acta Paediatr 87:1173-1179 10.1080/080352598750031176
10. Kvarnstrom G, Jakobsson P, Lennerstrand G (2001) Visual screening of Swedish children: An ophthalmological evaluation. Acta Ophthalmol Scand 79:240-244 10.1034/j.1600-0420.2001.790306.x
11. Meenken C, Assies J, van Nieuwenhuizen O, Holwerda-van der Maat WG, van Schooneveld MJ, Delleman WJ, Kinds G, Rothova A (1995) Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 79:581-584 1:STN:280:ByqA2M3lvVE%3D
12. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R (1996) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122:309-324 1:STN:280:BymA1cjhs1c%3D
13. Preslan M, Novak A (1996) Baltimore vision screening project. Ophthalmology 103:105-109
14. Roberts T, Frenkel JK (1990) Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc 196:249-256 1:STN:280:By%2BC38bpvVQ%3D
15. Rose GE (1991) Papillitis, retinal neovascularisation and recurrent retinal vein occlusion in Toxoplasma retinochoroiditis: A case report with uncommon clinical signs. Aust N Z j Ophthalmol 19:155-157 1:STN:280:By2D3s%2FgvVQ%3D
16. Sabates R, Pruett RC, Brockhurst RJ (1981) Fulminant ocular toxoplasmosis. Am J Ophthalmol 92:497-503 1:STN:280:Bi2D2czlslU%3D
17. Song A, Scott IU, Davis JL, Lam BL (2002) Atypical anterior optic neuropathy caused by toxoplasmosis. Am J Ophthalmol 133:162-164 10.1016/ S0002-9394(01)01211-9
18. Vutova K, Peicheva Z, Popova A, Markova V, Mincheva N, Todorov T (2002) Congenital toxoplasmosis: Eye manifestations in infants and children. Ann Trop Paediatr 22:213-218 10.1179/027249302125001507
19. Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, Peyron F (1999) Diagnosis of congenital toxoplasmosis at birth: What is the value of testing for IgM and IgA? Eur J Pediatr 158:645-649 10.1007/s004310051168
20. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567-1572 10.1542/peds.113.6.1567
21. Willerson D Jr, Aaberg TM, Reeser F, Meredith TA (1977) Unusual ocular presentation of acute toxoplasmosis. Br J Ophthalmol 61:693-698 588525